Search research articles
Contact Us
Filters
Showing results (101-110 of 191) with videos related to
Page
of 20
Sort By:
Neuro-Signals
|
February 10, 2016
Role of Serum Brain Derived Neurotrophic Factor and Central N-Acetylaspartate for Clinical Response under Antidepressive Pharmacotherapy
Sarah Nase, Stephan Köhler, Jacqueline Jennebach, et al.
Cells
|
March 14, 2026
Estetrol Enhances Mitochondrial Bioenergetics and Neurite Outgrowth in Cellular Models of Alzheimer's Disease
Amandine Grimm, Aurélien Riou, Clara Gaillard, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
October 19, 2022
Effect of anxiolytic drug silexan on sleep - a narrative review
Erich Seifritz, Siegfried Kasper, Hans-Jürgen Möller, et al.
Brain Sciences
|
April 3, 2021
Aerobic Exercise and Stretching as Add-On to Inpatient Treatment for Depression Have No Differential Effects on Stress-Axis Activity, Serum-BDNF, TNF-Alpha and Objective Sleep Measures
Christian Imboden, Markus Gerber, Johannes Beck, et al.
Biochimica Et Biophysica Acta
|
November 23, 2006
The amyloid precursor protein potentiates CHOP induction and cell death in response to ER Ca2+ depletion
Ekaterini Copanaki, Tina Schürmann, Anne Eckert, et al.
EMBO Reports
|
July 4, 2023
ER-mitochondria contacts and cholesterol metabolism are disrupted by disease-associated tau protein
Leonora Szabo, Nadia Cummins, Paolo Paganetti, et al.
Frontiers in Pharmacology
|
August 1, 2022
Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects
Patrick Vizeli, Isabelle Straumann, Urs Duthaler, et al.
The International Journal of Neuropsychopharmacology
|
November 7, 2022
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
Anna M Becker, Aaron Klaiber, Friederike Holze, et al.
Neuropsychobiology
|
September 5, 2015
Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression
Thorsten Mikoteit, Ulrich Hemmeter, Anne Eckert, et al.
Psychopharmacology
|
February 25, 2014
High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression
Thorsten Mikoteit, Johannes Beck, Anne Eckert, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 191) with videos related to
Sort By:
Page
of 20
Neuro-Signals
|
February 10, 2016
Role of Serum Brain Derived Neurotrophic Factor and Central N-Acetylaspartate for Clinical Response under Antidepressive Pharmacotherapy
Sarah Nase, Stephan Köhler, Jacqueline Jennebach, et al.
Cells
|
March 14, 2026
Estetrol Enhances Mitochondrial Bioenergetics and Neurite Outgrowth in Cellular Models of Alzheimer's Disease
Amandine Grimm, Aurélien Riou, Clara Gaillard, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
October 19, 2022
Effect of anxiolytic drug silexan on sleep - a narrative review
Erich Seifritz, Siegfried Kasper, Hans-Jürgen Möller, et al.
Brain Sciences
|
April 3, 2021
Aerobic Exercise and Stretching as Add-On to Inpatient Treatment for Depression Have No Differential Effects on Stress-Axis Activity, Serum-BDNF, TNF-Alpha and Objective Sleep Measures
Christian Imboden, Markus Gerber, Johannes Beck, et al.
Biochimica Et Biophysica Acta
|
November 23, 2006
The amyloid precursor protein potentiates CHOP induction and cell death in response to ER Ca2+ depletion
Ekaterini Copanaki, Tina Schürmann, Anne Eckert, et al.
EMBO Reports
|
July 4, 2023
ER-mitochondria contacts and cholesterol metabolism are disrupted by disease-associated tau protein
Leonora Szabo, Nadia Cummins, Paolo Paganetti, et al.
Frontiers in Pharmacology
|
August 1, 2022
Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects
Patrick Vizeli, Isabelle Straumann, Urs Duthaler, et al.
The International Journal of Neuropsychopharmacology
|
November 7, 2022
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
Anna M Becker, Aaron Klaiber, Friederike Holze, et al.
Neuropsychobiology
|
September 5, 2015
Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression
Thorsten Mikoteit, Ulrich Hemmeter, Anne Eckert, et al.
Psychopharmacology
|
February 25, 2014
High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression
Thorsten Mikoteit, Johannes Beck, Anne Eckert, et al.
Page
of 20